Sunday, June 15, 2008

Life of a Heroin Addict

I haven't actually viewed this film (Life of a Heroin Addict) viewable from the site below, but probably worth checking out.

Details below.

Rob

---

Introducing...Wired In films
Using the views and experiences of people whose lives have been affected by addiction, Wired In has produced a catalogue of film material which we will be showing through this Blog.


http://wiredinfilms.blogspot.com/

Friday, June 6, 2008

IDU Assessment in Asia

Please find a link below to a short but useful new report called:

BASELINE ASSESSMENT OF THE CURRENT STATUS OF RESOURCES, POLICIES AND SERVICES FOR INJECTING DRUG USE AND HIV/AIDS IN SOUTH AND SOUTH EAST ASIA.

http://www.unodc.un.or.th/drugsandhiv/documents/Report%20of%20the%20UN%20Regional%20Task%20Force%20Baseline%20Assessment%20Final%20Report.doc

Thursday, May 29, 2008

A brief overview of "Yaba" (Methamphetamines)

United Nations Office on Drugs and Crime

Yaba, the 'crazy medicine' of East Asia

19 May 2008 - Yaba, or 'crazy medicine' in Thai, is a tablet form of methamphetamine, and a very powerful stimulant. Introduced to East Asia during World War II to enhance soldiers' performance, methamphetamine has become increasingly popular in East Asia, particularly among young people. Yaba is now the main form of methamphetamine abused in Thailand, Laos and Cambodia as well as Viet Nam and Myanmar, where it is typically manufactured.

Mixed with caffeine and usually 30 per cent methamphetamine, the drug is a central nervous system stimulant. Although it comes in a pill form, yaba is usually crushed and smoked. Users get an intense 'burst' of energy, followed by increased activity, decreased appetite and a general sense of well-being. Once the effects wear off, the user 'crashes' and experiences prolonged periods of sleep and depression.

Like other forms of methamphetamine, long-term abuse of yaba can produce strong dependence. Users develop tolerance and require increasing amounts of the drug to feel the same effects. Excessive doses can result in convulsions, seizures and death from respiratory failure, stroke or heart failure. The drug can trigger aggressive and violent behaviour, and psychiatric disorders have also been associated with its use.

Traditionally used by occupational workers such as truck drivers, the use of yaba in East Asia shifted into youth culture about 10 years ago. Starting in Thailand and spreading into Laos, Cambodia and Viet Nam, yaba consumers in the region are now estimated in the millions. Recently, the drug has been spreading toward the Indian subcontinent; in 2007, a record 1,200,000 yaba tablets were confiscated in Bangladesh where there is a potentially very large market.

The development and spread of yaba in the region has been opportunistic. As UNODC expert Jeremy Douglas explains, "it is a drug that is cheap to manufacture and cheap to purchase. You introduce it somewhere and develop a market fairly quickly because it is cheap and highly addictive." With one tablet costing as little as US$ 1 in Cambodia to US$ 5 in Bangkok, the drug is very easy to produce if in possession of the necessary precursor materials. "You can have labs producing 10,000 tablets per hour hidden anywhere", he adds.

Unlike geographically confined, crop-based drugs, such as opium in Afghanistan, synthetic drugs like yaba can be produced anywhere in the world where there are weaknesses in law enforcement and in precursor chemical regulations. The portable and clandestine nature of production also makes it difficult to monitor and assess the situation systematically. "At the moment the information base is quite fractured", says Douglas. "In some parts of the world, we know it is there - we just don't know the extent to which it is."

To help address the issue, UNODC is launching the Global Synthetics Monitoring: Analysis, Reporting and Trends (SMART) Programme. Set up in hotspots and key priority regions of the world, SMART teams will assess data and information, thus enabling countries to strategically plan prevention and law enforcement responses.

Sunday, May 4, 2008

Drug users preventing overdose deaths

A new Yale Univ. study provides more evidence to support providing drug users with a cheap, safe product (naloxone) that helps them prevent deaths of their peers from overdose.

Story below.

Rob


Drug Addicts Can Learn How to Save Lives, Yale Researchers Find

New Haven, Conn. — Drug users can be taught to identify and quickly respond to overdoses of heroin or other opioids as effectively as medical experts, a Yale University study suggests.

The study supports efforts of some drug counselors, physicians and public health experts who have started community-based programs to train addicts and supply them with the opioid antagonist drug naloxone in order to respond to potentially fatal drug overdoses.

Naxolone, a medication lacking in abuse potential and routinely used by emergency medical personnel to treat heroin and other opioid overdoses, can be administered by a simple muscular injection. The drug temporarily combats effects of an overdose until medical help can arrive. Critics of such a harm-reduction strategy, however, have questioned whether drug users have the ability to recognize an overdose and can properly administer the drug. This study, recently published in the early online edition of the journal Addiction, suggests this concern is unwarranted.

“You have to keep people alive long enough to get access to drug treatment for their addiction,’’ said Traci Craig Green, a doctoral candidate in the Yale School of Public Health and lead author of the research “You can’t treat a dead person.”

Ten individuals who were regular users of heroin or other opioid drugs such as oxycodone or hydromorphone were enrolled in the study at each of six sites across the United States. They were divided into two groups, one with members who had previously received training in overdose response and one with members who had not. Individuals were interviewed to determine if they could recognize signs of opioid overdose and when it was appropriate to administer naloxone. Their responses were then compared to those given by a group of medical experts.

The training, conducted well before the interviews were done, included recognizing differences between overdoses caused by opioids and those caused by other substances such as cocaine, for which use of the drug naloxone is not indicated.

“The study shows opioid users with training can spot an opioid overdose, are less likely to miss true opioid overdoses, and can determine whether naloxone should be administered and when it should not be administered," Green said.

The study was funded by the National Institute of Mental Health. Other authors included Robert Heimer and Lauretta E. Grau from the school of public health.




FOR IMMEDIATE RELEASE: May 1, 2008

--------------------------------------------------------------------------------


About OPA | Contact Us

Copyright © 2007, Yale University

Sunday, April 27, 2008

DALYs for DC

Interesting story below about the expansion of needle exchange in DC, set for the summer.

Looks like DC is in for some significant DALYs gained through needle distribution!

Cheers
Rob


http://www.washingtonpost.com/wp-dyn/content/article/2008/04/24/AR2008042403383.html



More Money for Needle Exchanges
With Congressional Ban Lifted, City to Provide Funding

By Susan Levine
Washington Post Staff Writer
Friday, April 25, 2008; Page B04

Needle-exchange efforts in the District will expand significantly by summer as $494,000 in city funding -- the first local appropriation allowed in a decade -- begins flowing to four organizations on the front line of the fight against HIV/AIDS.

Last summer, Congress lifted a ban prohibiting the city from spending its tax dollars to provide drug addicts with clean needles, an approach that jurisdictions across the country have taken to stop the disease's transmission through shared, potentially contaminated syringes. No other city or state faced the same restriction, which dated to 1998.

More than half the money will go to PreventionWorks!, the sole group involved in such work during the ban, often despite tenuous private funding. It now will expand outreach to include more comprehensive disease screening of the people served through its mobile van.

Shannon Hader, director of the city's HIV/AIDS Administration, said yesterday that the other nonprofit groups that were awarded grants bring "three very different" approaches to the initiative.

Those recipients are Helping Individual Prostitutes Survive (HIPS), whose focus is men and women engaged in sex work in the District; Bread for the City, which assists the poor and homeless with a range of programs; and the Family Medical and Counseling Service, a more traditional health care provider in Ward 8.

Each will build on the work it does with intravenous drug users, Hader said. The grants are expected to double next year and be continued through 2010.

The District's rates of HIV and AIDS infection are among the worst in the country, with intravenous drug users accounting for a sizable portion of new cases annually.

Sunday, April 20, 2008

Safer Injecting Guide

FYI, a new guidebook on safer injecting for IDUs can be found at the below URL:



http://www.mqi.ie/docs/mqi_safer_injecting_guide_web.pdf



Rob

Heroin Blocking - Some new evidence

FYI


www.theage.com.au

Review of heroin-blocking implant urged

April 17, 2008 - 11:56PM


Use of a controversial stomach implant designed to block the effects of heroin must be urgently reined in, according to drug specialists who say addicts are being harmed.

A new report found that naltrexone implants commonly cause severe adverse reactions, including extreme dehydration and acute renal failure in those who are fitted with them.

Nine Sydney specialists writing in the Medical Journal of Australia have called for an urgent review of use of the product, which blocks the effects of heroin and stops cravings for about six months.

It has not been registered or rigorously tested in Australia but about 1,500 addicts have obtained it through the Therapeutic Goods Administration's Special Access Scheme for people with a life-threatening need.

Controversy has surrounded the use of the implants for several years, with advocates arguing they offer addicts the best chance of overcoming their addiction and opponents branding them dangerous and ineffective.

One study published last March linked the implant to five deaths.

A new study published has found that of 12 implant patients who were admitted to two Sydney hospitals last year, eight hospitalisations were implant-related.

Six were suffering severe dehydration, one had acute renal failure and another had an abscess at the implant site.

"These cases challenge the notion that a naltrexone implant is a safe procedure," said study leader Nicholas Lintzeris, a senior addiction specialist at the Sydney South West Area Health Service.

He called for the widespread and unregulated use of implants to be restricted until they have been properly tested for safety and effectiveness.

Professor Robert Ali, director of the Drug Alcohol Services Council in Adelaide, agreed the product should not be so widely available.

"The disturbing suggestions of mortality and morbidity from unregistered naltrexone implants makes a strong case for an independent review to determine whether this treatment is sufficiently safe for such widespread use," Prof Ali said.

However, another specialist, University of Western Australia Professor of Addiction Gary Hulse, said a trial he had undertaken had found the implant to be just as safe and effective as the oral form of the drug.

He defended its use and said many of the criticisms levelled at naltrexone occurred because people's withdrawals from heroin were not being managed properly.

© 2008 AAP